HIF-1α transcript levels were not affected by ET-1 treatment in CLL cells (data not shown), suggesting that its accumulation may be due to an increased HIF-1α stability as previously reported in melanoma cells [16]. Here, HIF1A is linked to B-cell chronic lymphocytic leukemia.